Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Arthritis Rheum. 2003 Jun;48(6):1521-9. doi: 10.1002/art.11143.
Arthritis Rheum. 2003.
PMID: 12794819